Congratulations to Adam Creamer, Pengfei Li, Francisco Lopez-Cuevas, Yuqi Shen and their collaborators who have been awarded funding in the sixth round of the OxCODE Funding Scheme.
The algorithms use information about a person\u2019s health conditions and simple blood tests to accurately predict a patient\u2019s chances of having a currently undiagnosed cancer.
Researchers and clinicians the Universities of Oxford, Newcastle and Central Lancashire and others have developed major new guidelines for the monitoring of patients with inflammatory bowel disease (IBD) to prevent them going on to develop bowel cancer.
Dr Karthik Ramasamy and team will assess a new mass spectrometry-based monitoring technique for its ability to predict and identify early disease relapse.
A study led by Oxford researchers has found that the number of steps taken daily may be more important for lowering cancer risk than the intensity of activity.
Dr Karin Hellner is awarded a CRUK Biology to Prevention grant to undertake pre-clinical research into a broad-coverage vaccine to treat chronic human papillomavirus infection.
Researchers from around the UK, led by the University of Oxford, have found that a new way of performing prostate biopsies is better at diagnosing prostate cancer, but takes longer to perform and is more painful for patients.
The funded research aims to identify circular RNA biomarkers for the early detection of normal colon cell transformation into precancerous and colorectal cancer states.
OxCODE researchers have authored a collaborative study which explored a new method for detecting bowel cancer, which was found to be more than 90% accurate at predicting which higher-risk people will develop this type of cancer in the future.
Global biopharma company GSK invests up to \u00a350 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer.
In the largest study to date into the link between diet and bowel cancer, Oxford researchers have found that an additional 300mg of calcium each day is associated with a 17% decrease in the risk of colorectal cancers.
Oxford University researchers have unveiled a new blood test \u2013 powered by machine learning \u2013 which shows real promise in detecting multiple types of cancer in their earliest stages, when the disease is hardest to detect.
On 10-11th December, we celebrated 5 years since the launch of OxCODE with a showcase of Oxford\u2019s most successful cancer early detection and prevention programmes.
Research from Professor Julia Hippisley-Cox shows Bangladeshi men face highest risks, while people in deprived areas are twice as likely to develop lung cancer compared to affluent areas, with important implications for NHS screening.
OxCODE researchers report that cancer data collected by national cancer registries is comparable to the data gathered directly by researchers in clinical studies. This could make cancer research much easier and less expensive in the future.
![\"\"](\"https://www.oxcode.ox.ac.uk/news/oxcode-funding-scheme-awards-2025/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n